Skip to content
Menu

B. Riley Securities Reiterates Buy on Precigen, Lowers Price Target to $11

Benzinga Newsdesk 1 day ago

Analyst RatingsNewsReiterationPrice Target

This page contains a summary, not the full article. Continue to benzinga.com to read the original report.

B. Riley Securities analyst Yuan Zhi reiterates Precigen (NASDAQ:PGEN) with a Buy and lowers the price target from $12 to $11.

B. Riley Securities analyst Yuan Zhi reiterates Precigen (NASDAQ:PGEN) with a Buy and lowers the price target from $12 to $11.

Read at benzinga.com